BiomeHub Biotechnologies, Florianópolis-SC, Brazil.
Laboratório de Virologia Aplicada, Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de Santa Catarina (UFSC), Florianópolis-SC, Brazil.
PLoS One. 2021 Feb 4;16(2):e0246544. doi: 10.1371/journal.pone.0246544. eCollection 2021.
To minimize sample dilution effect on SARS-CoV-2 pool testing, we assessed analytical and diagnostic performance of a new methodology, namely swab pooling. In this method, swabs are pooled at the time of collection, as opposed to pooling of equal volumes from individually collected samples. Paired analysis of pooled and individual samples from 613 patients revealed 94 positive individuals. Having individual testing as reference, no false-positives or false-negatives were observed for swab pooling. In additional 18,922 patients screened with swab pooling (1,344 pools), mean Cq differences between individual and pool samples ranged from 0.1 (Cr.I. -0.98 to 1.17) to 2.09 (Cr.I. 1.24 to 2.94). Overall, 19,535 asymptomatic patients were screened using 4,400 RT-qPCR assays. This corresponds to an increase of 4.4 times in laboratory capacity and a reduction of 77% in required tests. Therefore, swab pooling represents a major alternative for reliable and large-scale screening of SARS-CoV-2 in low prevalence populations.
为了最大程度地减少 SARS-CoV-2 混合检测对样本稀释的影响,我们评估了一种新方法,即拭子混合检测的分析和诊断性能。在这种方法中,拭子在采集时混合,而不是将来自单独采集的样本的等量体积混合。对 613 名患者的混合和单独样本的配对分析显示 94 名阳性个体。以单独检测为参考,拭子混合检测未观察到假阳性或假阴性。在另外 18922 名使用拭子混合检测(1344 个池)筛查的患者中,个体样本和池样本之间的 Cq 差异平均值从 0.1(Cr.I. -0.98 至 1.17)到 2.09(Cr.I. 1.24 至 2.94)。总体而言,使用 4400 次 RT-qPCR 检测对 19535 名无症状患者进行了筛查。这相当于实验室能力提高了 4.4 倍,所需检测减少了 77%。因此,拭子混合检测是在低流行人群中进行可靠的大规模 SARS-CoV-2 筛查的主要替代方法。